AAV-TNFSF12 mab (BGF17) Cas9-GFP-ACACB for B Cell Engineering (CAT#: BGS-0524-CR38)

The product is a highly efficient, inducible Cas9-GFP-ACACB gene-editing based novel AAV packaging system that can be used to mediate researches involving anti-TNFSF12 mab (BGF17) in Horse B cell engineering.

Datasheet

Specifications

Clone BGF17
Host Humanized
Packaging Cell Line HEK 293
Vector Promoter U6
Rep Rep68
Capsid P24
Envelope Env
Matrix C-terminal
Size ~12kb
Genome ssDNA
Virus Type AAV
Cofactor Requirement No GTP, CTP, or UTP
Particles/mL 7.8 × 10¹¹
PFU/mL 4.7 × 10¹¹
TU/mL 8.5 × 10¹¹
Cas9 Cas9-GFP
sgRNA ACACB
Engineered B Cell Horse B cells

Target Information

Target TNFSF12
Alternative Names TNFSF12; APO3L; DR3LG; TWEAK; TNLG4A; tumor necrosis factor superfamily member 12; TNF superfamily member 12

Product Properties

Format Liquid
Shipping The product is shipped by dry ice.
Storage Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles.
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products